RESUMEN
Demyelination leads to a loss of neurons, which results in, among other consequences, a severe reduction in locomotor function, and underlies several diseases in humans including multiple sclerosis and polyneuropathies. Considerable clinical progress has been made in counteracting demyelination. However, there remains a need for novel methods that reduce demyelination while concomitantly achieving remyelination, thus complementing the currently available tools to ameliorate demyelinating diseases. In this study, we used an established zebrafish demyelination model to test selected compounds, following a screening in cell culture experiments and in a mouse model of spinal cord injury that was aimed at identifying beneficial functions of the neural cell adhesion molecule L1. In comparison to mammalian nervous system disease models, the zebrafish allows testing of potentially promotive compounds more easily than what is possible in mammals. We found that our selected compounds tacrine and duloxetine significantly improved remyelination in the peripheral and central nervous system of transgenic zebrafish following pharmacologically induced demyelination. Given that both molecules are known to positively affect functions other than those related to L1 and in other disease contexts, we propose that their combined beneficial function raises hope for the use of these compounds in clinical settings.
Asunto(s)
Enfermedades Desmielinizantes/patología , Molécula L1 de Adhesión de Célula Nerviosa/metabolismo , Bibliotecas de Moléculas Pequeñas/farmacología , Pez Cebra/fisiología , Animales , Diferenciación Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Clorhidrato de Duloxetina/farmacología , Larva/efectos de los fármacos , Larva/ultraestructura , Sistema de la Línea Lateral/efectos de los fármacos , Sistema de la Línea Lateral/patología , Actividad Motora/efectos de los fármacos , Oligodendroglía/efectos de los fármacos , Oligodendroglía/metabolismo , Oligodendroglía/patología , Regeneración/efectos de los fármacos , Remielinización/efectos de los fármacos , Células de Schwann/efectos de los fármacos , Células de Schwann/patología , Médula Espinal/patología , Tacrina/farmacologíaRESUMEN
Exposure to ototoxic drugs is a significant cause of hearing loss that affects about 30 thousand children with potentially serious physical, social and psychological dysfunctions every year. Cisplatin (CP) and aminoglycosides are effective antineoplastic or bactericidal drugs, and their application has a high probability of ototoxicity which results from the death of hair cells (HCs). Here, we describe the therapeutic effect of the flavonoid compound naringin (Nar) against ototoxic effects of cisplatin and aminoglycosides include gentamicin (GM) and neomycin (Neo) in zebrafish HCs. Animals incubated with Nar (100-400 µmol/L) were protected against the pernicious effects of CP (150-250 µmol/L), GM (50-150 µmol/L) and Neo (50-150 µmol/L). We also provide evidence for the potential mechanism of Nar against ototoxicity, including antioxidation, anti-apoptosis, promoting proliferation and hair cell regeneration. We found that mRNA levels of the apoptotic- and pyroptosis-related genes are regulated by Nar both in vivo and in vitro. Finally, by proving that Nar does not affect the anti-tumour efficacy of CP and antibacterial activity of aminoglycosides in vitro, we highlight its value in clinical application. In conclusion, these results unravel a novel therapeutic role for Nar as an otoprotective drug against the adverse effects of CP and aminoglycosides.
Asunto(s)
Aminoglicósidos/efectos adversos , Cisplatino/efectos adversos , Flavanonas/farmacología , Células Ciliadas Auditivas/patología , Sistema de la Línea Lateral/patología , Transducción de Señal , Animales , Muerte Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Cilios/efectos de los fármacos , Cilios/metabolismo , Cilios/patología , Gentamicinas/efectos adversos , Células Ciliadas Auditivas/efectos de los fármacos , Sistema de la Línea Lateral/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Neomicina/toxicidad , Estrés Oxidativo/efectos de los fármacos , Sustancias Protectoras/farmacología , Piroptosis/efectos de los fármacos , Piroptosis/genética , Especies Reactivas de Oxígeno/metabolismo , Regeneración/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Pruebas de Toxicidad Aguda , Pez CebraRESUMEN
AIM: The present review aimed to consolidate and analyze the recent information about the use of zebrafish in studies concerning cisplatin-induced ototoxicity and otoprotection. MATERIAL AND METHODS: The PubMed, Web of Science, and Scopus databanks were searched using the following MESH terms: zebrafish, cisplatin, ototoxicity. The identified publications were screened according to inclusion and exclusion criteria and the 26 qualifying manuscripts were included in the full-text analysis. The experimental protocols, including cisplatin concentrations, the exposure duration and the outcome measurements used in zebrafish larvae studies, were evaluated and the reported knowledge was summarized. RESULTS: Twenty-six substances protecting from cisplatin-induced toxicity were identified with the use of zebrafish larvae. These substances include quinine, salvianolic acid B, berbamine 6, benzamil, quercetin, dexmedetomidine, dexamethsanone, quinoxaline, edaravone, apocynin, dimethyl sulfoxide, KR-22335, SRT1720, ORC-13661, 3-MA, D-methionine, mdivi-1, FUT-175, rapamycin, Z-LLF-CHO, ATX, NAC, CYM-5478, CHCP1, CHCP2 and leupeptin. The otoprotective effects of compounds were attributed to their anti-ROS, anti-apoptotic and cisplatin uptake-blocking properties. The broadest range of protection was achieved when the experimental flow used preconditioning with an otoprotective compound and later a co-incubation with cisplatin. Protection against a high concentration of cisplatin was observed only in protocols using short exposure times (4 and 6 h). CONCLUSIONS: The data extracted from the selected papers confirm that despite the differences between the human and the zebra fish hearing thresholds (as affected by cisplatin), the sensory cells of zebrafish and larval zebrafish are a valuable tool which could be used: (i) for the discovery of novel otoprotective substances and compounds; (ii) to screen their side effects and (iii) to extend the knowledge on the mechanisms of cisplatin-induced inner ear damage. For future studies, the development of a consensus experimental protocol is highly recommended.
Asunto(s)
Cisplatino , Enfermedades del Oído/prevención & control , Sistema de la Línea Lateral/efectos de los fármacos , Sustancias Protectoras/farmacología , Pez Cebra , Animales , Apoptosis/efectos de los fármacos , Citoprotección , Modelos Animales de Enfermedad , Enfermedades del Oído/inducido químicamente , Enfermedades del Oído/metabolismo , Enfermedades del Oído/patología , Sistema de la Línea Lateral/metabolismo , Sistema de la Línea Lateral/patología , Ototoxicidad , Especies Reactivas de Oxígeno/metabolismo , Especificidad de la Especie , Pez Cebra/embriologíaRESUMEN
Cochlear hair cells in human beings cannot regenerate after loss; however, those in fish and other lower species can. Recently, the role of inflammation in hair cell regeneration has been attracting the attention of scientists. In the present study, we investigated how suppression of inflammatory factors affects hair cell regeneration and the functional recovery of regenerated hair cells in zebrafish. We killed hair cells in the lateral line of zebrafish larvae with CuSO4 to induce an inflammatory response and coapplied BRS-28, an anti-inflammatory agent to suppress the inflammation. The recovery of the hair cell number and rheotaxis was slower when CuSO4 and BRS-28 were coapplied than when CuSO4 was applied alone. The recovery of hair cell count lagged behind that of the calcium imaging signal during the regeneration. The calcium imaging signal in the neuromasts in the inflammation-inhibited group was weaker than that in the noninflammation-inhibited group at the early stage of regeneration, although it returned to normal at the late stage. Our study demonstrates that suppressing inflammation by BRS-28 delays hair cell regeneration and functional recovery when hair cells are damaged. We suspect that BRS-28 inhibits pro-inflammatory factors and thereby reduces the migration of macrophages to delay the regeneration of hair cells.
Asunto(s)
Células Ciliadas Vestibulares/citología , Inflamación/genética , Regeneración/genética , Pez Cebra/genética , Animales , Muerte Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Sulfato de Cobre/farmacología , Células Ciliadas Vestibulares/metabolismo , Humanos , Inflamación/inducido químicamente , Inflamación/patología , Larva/genética , Larva/crecimiento & desarrollo , Sistema de la Línea Lateral/crecimiento & desarrollo , Sistema de la Línea Lateral/patología , Macrófagos , Pez Cebra/crecimiento & desarrolloRESUMEN
Dose-limiting toxicities for cisplatin administration, including ototoxicity and nephrotoxicity, impact the clinical utility of this effective chemotherapy agent and lead to lifelong complications, particularly in pediatric cancer survivors. Using a two-pronged drug screen employing the zebrafish lateral line as an in vivo readout for ototoxicity and kidney cell-based nephrotoxicity assay, we screened 1280 compounds and identified 22 that were both oto- and nephroprotective. Of these, dopamine and L-mimosine, a plant-based amino acid active in the dopamine pathway, were further investigated. Dopamine and L-mimosine protected the hair cells in the zebrafish otic vesicle from cisplatin-induced damage and preserved zebrafish larval glomerular filtration. Importantly, these compounds did not abrogate the cytotoxic effects of cisplatin on human cancer cells. This study provides insights into the mechanisms underlying cisplatin-induced oto- and nephrotoxicity and compelling preclinical evidence for the potential utility of dopamine and L-mimosine in the safer administration of cisplatin.
Asunto(s)
Cisplatino , Sustancias Protectoras/farmacología , Animales , Antineoplásicos/farmacología , Antineoplásicos/toxicidad , Línea Celular Tumoral , Cisplatino/farmacología , Cisplatino/toxicidad , Dopamina/farmacología , Combinación de Medicamentos , Células Ciliadas Auditivas/efectos de los fármacos , Células Ciliadas Auditivas/patología , Humanos , Riñón/efectos de los fármacos , Riñón/patología , Sistema de la Línea Lateral/efectos de los fármacos , Sistema de la Línea Lateral/patología , Mimosina/farmacología , Modelos Animales , Pez CebraRESUMEN
Zebrafish behavior is influenced by the lateral line hair cells and muscles. Drug-induced behavioral changes can serve as indicators in the evaluation of drug toxicity. The aminoglycoside family of antibiotics comprise a number of agents, including neomycin (NM) and gentamicin (GM). We hypothesized that NM and GM exert different effects on zebrafish larvae through their action on the lateral line and muscle fibers, inducing different swimming behavioral patterns such as locomotor behavior and the startle response. In this study, 125 µM NM and 5, 10, 20 µM GM induced hair cell damage in the anterior and posterior lateral lines of zebrafish larvae. However, unlike GM, 125 µM NM also caused muscle damage. Locomotor behavior was decreased in the 125 µM NM-exposed group compared to the group exposed to GM. Furthermore, 125 µM NM exposure induced significantly different patterns of various indices of startle behavior compared with the GM exposure groups. Additionally, the larvae exhibited different startle responses depending on the concentration of GM. These results suggest that GM may be the drug-of-choice for analyzing behavioral changes in zebrafish caused by damage to the lateral line alone. Our study highlights the importance of confirming muscle damage in behavioral analyses using zebrafish.
Asunto(s)
Aminoglicósidos/toxicidad , Conducta Animal/efectos de los fármacos , Sistema de la Línea Lateral/efectos de los fármacos , Músculos/efectos de los fármacos , Animales , Femenino , Sistema de la Línea Lateral/patología , Masculino , Neuronas Motoras/efectos de los fármacos , Neuronas Motoras/patología , Músculos/patología , Reflejo de Sobresalto/efectos de los fármacos , Células Receptoras Sensoriales/efectos de los fármacos , Células Receptoras Sensoriales/patología , Natación , Pez CebraRESUMEN
Excessive noise exposure damages sensory hair cells, leading to permanent hearing loss. Zebrafish are a highly tractable model that have advanced our understanding of drug-induced hair cell death, yet no comparable model exists for noise exposure research. We demonstrate the utility of zebrafish as model to increase understanding of hair cell damage from acoustic trauma and develop protective therapies. We created an acoustic trauma system using underwater cavitation to stimulate lateral line hair cells. We found that acoustic stimulation resulted in exposure time- and intensity-dependent lateral line and saccular hair cell damage that is maximal at 48-72 h post-trauma. The number of TUNEL+ lateral line hair cells increased 72 h post-exposure, whereas no increase was observed in TUNEL+ supporting cells, demonstrating that acoustic stimulation causes hair cell-specific damage. Lateral line hair cells damaged by acoustic stimulation regenerate within 3 d, consistent with prior regeneration studies utilizing ototoxic drugs. Acoustic stimulation-induced hair cell damage is attenuated by pharmacological inhibition of protein synthesis or caspase activation, suggesting a requirement for translation and activation of apoptotic signaling cascades. Surviving hair cells exposed to acoustic stimulation showed signs of synaptopathy, consistent with mammalian studies. Finally, we demonstrate the feasibility of this platform to identify compounds that prevent acoustic trauma by screening a small redox library for protective compounds. Our data suggest that acoustic stimulation results in lateral line hair cell damage consistent with acoustic trauma research in mammals, providing a highly tractable model for high-throughput genetic and drug discovery studies.
Asunto(s)
Células Ciliadas Vestibulares , Pérdida Auditiva Provocada por Ruido , Sistema de la Línea Lateral , Regeneración Nerviosa/fisiología , Estimulación Acústica , Animales , Animales Modificados Genéticamente , Modelos Animales de Enfermedad , Células Ciliadas Vestibulares/patología , Células Ciliadas Vestibulares/fisiología , Pérdida Auditiva Provocada por Ruido/etiología , Pérdida Auditiva Provocada por Ruido/patología , Pérdida Auditiva Provocada por Ruido/fisiopatología , Larva , Sistema de la Línea Lateral/lesiones , Sistema de la Línea Lateral/patología , Sistema de la Línea Lateral/fisiología , Regeneración Nerviosa/efectos de los fármacos , Pez CebraRESUMEN
Hearing loss caused by aging, noise, cisplatin toxicity, or other insults affects 360 million people worldwide, but there are no Food and Drug Administration-approved drugs to prevent or treat it. We screened 4,385 small molecules in a cochlear cell line and identified 10 compounds that protected against cisplatin toxicity in mouse cochlear explants. Among them, kenpaullone, an inhibitor of multiple kinases, including cyclin-dependent kinase 2 (CDK2), protected zebrafish lateral-line neuromasts from cisplatin toxicity and, when delivered locally, protected adult mice and rats against cisplatin- and noise-induced hearing loss. CDK2-deficient mice displayed enhanced resistance to cisplatin toxicity in cochlear explants and to cisplatin- and noise-induced hearing loss in vivo. Mechanistically, we showed that kenpaullone directly inhibits CDK2 kinase activity and reduces cisplatin-induced mitochondrial production of reactive oxygen species, thereby enhancing cell survival. Our experiments have revealed the proapoptotic function of CDK2 in postmitotic cochlear cells and have identified promising therapeutics for preventing hearing loss.
Asunto(s)
Cisplatino/efectos adversos , Quinasa 2 Dependiente de la Ciclina/antagonistas & inhibidores , Pérdida Auditiva Provocada por Ruido/inducido químicamente , Pérdida Auditiva Provocada por Ruido/tratamiento farmacológico , Inhibidores de Proteínas Quinasas/uso terapéutico , Animales , Benzazepinas/farmacología , Benzazepinas/uso terapéutico , Muerte Celular/efectos de los fármacos , Línea Celular Tumoral , Quinasa 2 Dependiente de la Ciclina/metabolismo , Citoprotección/efectos de los fármacos , Resistencia a Medicamentos , Células Germinativas/metabolismo , Células Ciliadas Auditivas/efectos de los fármacos , Células Ciliadas Auditivas/patología , Indoles/farmacología , Indoles/uso terapéutico , Sistema de la Línea Lateral/efectos de los fármacos , Sistema de la Línea Lateral/patología , Ratones Endogámicos C57BL , Ratones Noqueados , Mitocondrias/metabolismo , Ratas , Especies Reactivas de Oxígeno/metabolismo , Bibliotecas de Moléculas Pequeñas/análisis , Pez CebraRESUMEN
Zebrafish have emerged as a powerful biological system for drug development against hearing loss. Zebrafish hair cells, contained within neuromasts along the lateral line, can be damaged with exposure to ototoxins, and therefore, pre-exposure to potentially otoprotective compounds can be a means of identifying promising new drug candidates. Unfortunately, anatomical assays of hair cell damage are typically low-throughput and labor intensive, requiring trained experts to manually score hair cell damage in fluorescence or confocal images. To enhance throughput and consistency, our group has developed an automated damage-scoring algorithm based on machine-learning techniques that produce accurate damage scores, eliminate potential operator bias, provide more fidelity in determining damage scores that are between two levels, and deliver consistent results in a fraction of the time required for manual analysis. The system has been validated against trained experts using linear regression, hypothesis testing, and the Pearson's correlation coefficient. Furthermore, performance has been quantified by measuring mean absolute error for each image and the time taken to automatically compute damage scores. Coupling automated analysis of zebrafish hair cell damage to behavioral assays for ototoxicity produces a novel drug discovery platform for rapid translation of candidate drugs into preclinical mammalian models of hearing loss.
Asunto(s)
Cisplatino/toxicidad , Células Ciliadas Auditivas/efectos de los fármacos , Ensayos Analíticos de Alto Rendimiento/métodos , Sistema de la Línea Lateral/efectos de los fármacos , Pruebas de Toxicidad/métodos , Pez Cebra/crecimiento & desarrollo , Animales , Antineoplásicos/toxicidad , Evaluación Preclínica de Medicamentos , Potenciales Evocados Auditivos/efectos de los fármacos , Células Ciliadas Auditivas/patología , Humanos , Larva/efectos de los fármacos , Sistema de la Línea Lateral/patología , Modelos Animales , Variaciones Dependientes del Observador , Pez Cebra/fisiologíaRESUMEN
Experiments on the flow-sensitive lateral line system of fishes have provided important insights into the function and sensory transduction of vertebrate hair cells. A common experimental approach has been to pharmacologically block lateral line hair cells and measure how behavior changes. Cobalt chloride (CoCl2) blocks the lateral line by inhibiting calcium movement through the membrane channels of hair cells, but high concentrations can be toxic, making it unclear whether changes in behavior are due to a blocked lateral line or poor health. Here, we identify a non-toxic treatment of cobalt that completely blocks lateral line hair cells. We exposed 5-day post fertilization zebrafish larvae to CoCl2 concentrations ranging from 1 to 20 mM for 15 min and measured 1) the spiking rate of the afferent neurons contacting hair cells and 2) the larvae's health and long-term survival. Our results show that a 15-min exposure to 5 mM CoCl2 abolishes both spontaneous and evoked afferent firing. This treatment does not change swimming behavior, and results in >85% survival after 5 days. Weaker treatments of CoCl2 did not eliminate afferent activity, while stronger treatments caused close to 50% mortality. Our work provides a guideline for future zebrafish investigations where physiological confirmation of a blocked lateral line system is required.
Asunto(s)
Señalización del Calcio/efectos de los fármacos , Cobalto/farmacología , Células Ciliadas Auditivas/efectos de los fármacos , Sistema de la Línea Lateral/efectos de los fármacos , Mecanotransducción Celular/efectos de los fármacos , Animales , Cobalto/toxicidad , Relación Dosis-Respuesta a Droga , Potenciales Evocados/efectos de los fármacos , Células Ciliadas Auditivas/metabolismo , Células Ciliadas Auditivas/patología , Larva/efectos de los fármacos , Larva/metabolismo , Sistema de la Línea Lateral/metabolismo , Sistema de la Línea Lateral/patología , Factores de Tiempo , Pez Cebra/embriologíaRESUMEN
Eighteen supplement drugs were screened using hair cells to determine a protective effect against the adverse effects of neomycin by using the zebrafish lateral line. The zebrafish were administered the supplement drugs 1 h before neomycin exposure. One hour later, animals were fixed in paraformaldehyde. Dose-response curves were generated to evaluate the protective effect on hair cells. The screen identified 3 supplements (quercetin, catechin and tannic acid). Three minutes after exposure to neomycin, increased antioxidant activity was found in the lateral line hair cells, as determined by the analysis of oxidative stress. Quercetin decreases antioxidant activity. The identified drugs were also investigated to determine whether they protect the cochlea against noise-induced hearing loss in guinea pigs. The drugs were administered via the intraperitoneal route in the guinea pigs 3 days before and 4 days after noise exposure. Seven days after noise exposure (130-dB sound pressure level for 3 h), the auditory brainstem response threshold shifts were assessed. We observed that the auditory brainstem response threshold shift was significantly less in the quercetin group than in the vehicle control group. The results of our study indicate that screening drugs using zebrafish can determine additional protective drugs for the inner ear.
Asunto(s)
Células Ciliadas Auditivas Externas/efectos de los fármacos , Sistema de la Línea Lateral/efectos de los fármacos , Quercetina/farmacología , Animales , Antioxidantes/metabolismo , Umbral Auditivo/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Potenciales Evocados Auditivos del Tronco Encefálico/efectos de los fármacos , Cobayas , Células Ciliadas Auditivas Externas/patología , Células Ciliadas Auditivas Externas/fisiología , Sistema de la Línea Lateral/patología , Sistema de la Línea Lateral/fisiopatología , Masculino , Neomicina/administración & dosificación , Neomicina/toxicidad , Ruido/efectos adversos , Sustancias Protectoras/administración & dosificación , Sustancias Protectoras/farmacología , Quercetina/administración & dosificación , Pez CebraRESUMEN
A severe fungal infection affecting the head and lateral line system was diagnosed in 7 captive scalloped hammerhead sharks Sphyrna lewini in an aquarium in Thailand. Extensive and severe necrotizing cellulitis was consistently observed microscopically along the cephalic and lateral line canals in conjunction with positive fungal cultures for Fusarium sp. Molecular phylogenetic analysis was performed from 3 isolates based on the nucleotide sequences containing internally transcribed spacer (ITS) and a portion of 5.8S and 28S rDNA. The fungus was highly homologous (100%) and closely related to F. solani species complex 2 (FSSC 2), which belongs to Clade 3 of the FSSC. Our results illustrate the histopathological findings and expand upon our knowledge of the prevalence of invasive fusariosis in the head and lateral line system of hammerhead sharks.
Asunto(s)
Enfermedades de los Peces/microbiología , Fusariosis/veterinaria , Fusarium/clasificación , Sistema de la Línea Lateral/microbiología , Tiburones , Animales , ADN de Hongos/clasificación , ADN de Hongos/genética , ADN Intergénico/clasificación , ADN Intergénico/genética , Enfermedades de los Peces/patología , Fusariosis/patología , Fusarium/aislamiento & purificación , Sistema de la Línea Lateral/patología , Filogenia , ARN de Hongos/genética , ARN Ribosómico 28S/genéticaRESUMEN
Sodium selenite is a trace element essential for many physiological functions in the body. It is involved in various biological processes; it acts as a cofactor for antioxidant enzymes that protect against free radicals and is reported to limit metal-mediated oxidative DNA damage. In the present study, we investigated the effect of sodium selenite on neomycin ototoxicity in wild-type and transgenic zebrafish (Brn3C: EGFP). Five or six days post-fertilization, zebrafish larvae were co-exposed to 125 µM neomycin and various concentrations (10 µM, 100 µM, 250 µM, and 500 µM) of sodium selenite for 1 h. Hair cells within neuromasts of the supraorbital (SO1 and SO2), otic (O1), and occipital (OC1) lateral lines were analyzed by fluorescence microscopy (n = 10 fish per treatment). Hair cell survival was estimated as the ratio of the hair cell numbers in each group compared to those of the control group that were not exposed to neomycin. Apoptosis and hair cell damage of neuromasts were evaluated using the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL) assay and 2-[4-(dimethylamino) styryl]-N-ethylpyridinium iodide (DASPEI) assay, respectively. Ultrastructural changes were evaluated using scanning electron microscopy and transmission electron microscopy. Neuromast hair cells were preserved in zebrafish exposed to 125 µM neomycin and 500 µM sodium selenite for 1 h. Sodium selenite protected against neomycin-induced hair cell loss of neuromasts, reduced apoptosis, and prevented zebrafish ultrastructural changes. We propose that sodium selenite protects against neomycin-induced hair cell damage by inhibiting apoptosis, decreasing the disarray of stereocilia, and preventing ultrastructural changes in the neuromast hair cells of the zebrafish.
Asunto(s)
Células Ciliadas Auditivas/patología , Sustancias Protectoras/farmacología , Selenito de Sodio/farmacología , Animales , Apoptosis/efectos de los fármacos , Bioensayo , Recuento de Células , Modelos Animales de Enfermedad , Células Ciliadas Auditivas/efectos de los fármacos , Células Ciliadas Auditivas/ultraestructura , Etiquetado Corte-Fin in Situ , Sistema de la Línea Lateral/efectos de los fármacos , Sistema de la Línea Lateral/patología , Sistema de la Línea Lateral/ultraestructura , Microscopía Fluorescente , Neomicina , Neuronas/citología , Neuronas/efectos de los fármacos , Pez Cebra/crecimiento & desarrolloRESUMEN
Sensory hair cells are the mechanotransductive receptors that detect gravity, sound, and vibration in all vertebrates. Damage to these sensitive receptors often results in deficits in vestibular function and hearing. There are currently two main reasons for studying the process of hair cell loss in fishes. First, fishes, like other non-mammalian vertebrates, have the ability to regenerate hair cells that have been damaged or lost via exposure to ototoxic chemicals or acoustic overstimulation. Thus, they are used as a biomedical model to understand the process of hair cell death and regeneration and find therapeutics that treat or prevent human hearing loss. Secondly, scientists and governmental natural resource managers are concerned about the potential effects of intense anthropogenic sounds on aquatic organisms, including fishes. Dr. Arthur N. Popper and his students, postdocs and research associates have performed pioneering experiments in both of these lines of fish hearing research. This review will discuss the current knowledge regarding the causes and consequences of both lateral line and inner ear hair cell damage in teleost fishes.
Asunto(s)
Peces/fisiología , Células Ciliadas Auditivas/patología , Pérdida Auditiva/fisiopatología , Audición/fisiología , Sistema de la Línea Lateral/fisiopatología , Vestíbulo del Laberinto/fisiopatología , Animales , Peces/clasificación , Humanos , Sistema de la Línea Lateral/patología , Recuperación de la Función/fisiología , Regeneración/fisiología , Vestíbulo del Laberinto/patologíaRESUMEN
Hair cell-driven mechanosensory systems are crucial for successful execution of a number of behaviors in fishes, and have emerged as good models for exploring questions relevant to human hearing. This review focuses on ototoxic effects in the inner ear and lateral line system of fishes. We specifically examine studies where chemical ototoxins such as aminoglycoside antibiotics have been employed as tools to disable the lateral line. Lateral line ablation results in alterations to feeding behavior and orientation to water current in a variety of species. However, neither behavior is abolished in the presence of additional sensory cues, supporting the hypothesis that many fish behaviors are driven by multisensory integration. Within biomedical research, the larval zebrafish lateral line has become an important model system for understanding signaling mechanisms that contribute to hair cell death and for developing novel pharmacological therapies that protect hair cells from ototoxic damage. Furthermore, given that fishes robustly regenerate damaged hair cells, ototoxin studies in fishes have broadened our understanding of the molecular and genetic events in an innately regenerative system, offering potential targets for mammalian hair cell regeneration. Collectively, studies of fish mechanosensory systems have yielded insight into fish behavior and in mechanisms of hair cell death, protection, and regeneration.
Asunto(s)
Oído Interno/fisiopatología , Peces/fisiología , Sistema de la Línea Lateral/efectos de los fármacos , Sistema de la Línea Lateral/fisiopatología , Pez Cebra/fisiología , Aminoglicósidos/toxicidad , Animales , Antibacterianos/toxicidad , Oído Interno/efectos de los fármacos , Oído Interno/patología , Peces/clasificación , Células Ciliadas Auditivas/efectos de los fármacos , Células Ciliadas Auditivas/fisiología , Humanos , Larva/efectos de los fármacos , Larva/fisiología , Sistema de la Línea Lateral/patologíaRESUMEN
The hair cells of the lateral line system of fishes are morphologically and physiologically similar to the hair cells of the mammalian inner ear, also sharing its molecular characteristics. For this reason, it has been used as a powerful animal model to analyze in vivo ototoxicity. In this work, we examined the dose-dependent effects of two potent ototoxic aminoglycosides, neomycin and gentamicin, on the hair cells of two selected neuromasts (L1 and T1, the first of the trunk and the terminal located in the fin, respectively) of the lateral line in the ET4 transgenic zebrafish line. The hair cells of this strain selectively and constitutively display fluorescence. The fish were treated for 24 h at different doses (1, 2.5, 5, 10 and 100 µM levels) of both aminoglycosides. Immediately after treatment the morphology and the number of cells in L1 and T were analyzed under a fluorescence microscope. The results show that neomycin and gentamicin have different effects on the hair cell death at the same concentration, showing also different toxicity in L1 and T1 neuromasts. The toxicity observed in the hair cells of T1 neuromast was less than in L1 especially for the gentamicin treatment. These results demonstrate different sensitivity of hair cells of the lateral line to ototoxic drugs according to topographical localization and suggest the in vivo assay of the L1 neuromast of zebrafish larva and low doses of neomycin as an ideal model to study ototoxicity induced by aminoglycosides.
Asunto(s)
Aminoglicósidos/toxicidad , Sistema de la Línea Lateral/efectos de los fármacos , Sistema de la Línea Lateral/patología , Neuronas Aferentes/efectos de los fármacos , Pez Cebra/fisiología , Animales , Animales Modificados Genéticamente , Recuento de Células , Gentamicinas/toxicidad , Larva , Neomicina/toxicidad , Células-Madre Neurales/efectos de los fármacosRESUMEN
Sensorineural hearing loss is a normal consequence of aging and results from a variety of extrinsic challenges such as excessive noise exposure and certain therapeutic drugs, including the aminoglycoside antibiotics. The proximal cause of hearing loss is often death of inner ear hair cells. The signaling pathways necessary for hair cell death are not fully understood and may be specific for each type of insult. In the lateral line, the closely related aminoglycoside antibiotics neomycin and gentamicin appear to kill hair cells by activating a partially overlapping suite of cell death pathways. The lateral line is a system of hair cell-containing sense organs found on the head and body of aquatic vertebrates. In the present study, we use a combination of pharmacologic and genetic manipulations to assess the contributions of p53, Bax, and Bcl2 in the death of zebrafish lateral line hair cells. Bax inhibition significantly protects hair cells from neomycin but not from gentamicin toxicity. Conversely, transgenic overexpression of Bcl2 attenuates hair cell death due to gentamicin but not neomycin, suggesting a complex interplay of pro-death and pro-survival proteins in drug-treated hair cells. p53 inhibition protects hair cells from damage due to either aminoglycoside, with more robust protection seen against gentamicin. Further experiments evaluating p53 suggest that inhibition of mitochondrial-specific p53 activity confers significant hair cell protection from either aminoglycoside. These results suggest a role for mitochondrial p53 activity in promoting hair cell death due to aminoglycosides, likely upstream of Bax and Bcl2.
Asunto(s)
Células Ciliadas Auditivas/patología , Sistema de la Línea Lateral/patología , Proteínas Proto-Oncogénicas c-bcl-2/genética , Proteína p53 Supresora de Tumor/genética , Proteínas de Pez Cebra/genética , Pez Cebra/genética , Proteína X Asociada a bcl-2/genética , Animales , Muerte Celular/efectos de los fármacos , Muerte Celular/fisiología , Femenino , Regulación del Desarrollo de la Expresión Génica , Gentamicinas/toxicidad , Células Ciliadas Auditivas/fisiología , Sistema de la Línea Lateral/embriología , Masculino , Neomicina/toxicidad , Inhibidores de la Síntesis de la Proteína/toxicidad , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Pez Cebra/embriología , Proteínas de Pez Cebra/metabolismo , Proteína X Asociada a bcl-2/metabolismoRESUMEN
This article documents an epizootic of inflammation and neoplasia selectively affecting the lateral line system of lake trout (Salvelinus namaycush) in 4 Finger Lakes in New York from 1985 to 1994. We studied more than 100 cases of this disease. Tumors occurred in 8% (5/64) of mature and 21% (3/14) of immature lake trout in the most severely affected lake. Lesions consisted of 1 or more neoplasm(s) in association with lymphocytic inflammation, multifocal erosions, and ulcerations of the epidermis along the lateral line. Lesions progressed from inflammatory to neoplastic, with 2-year-old lake trout showing locally extensive, intense lymphocytic infiltrates; 2- to 3-year-old fish having multiple, variably sized white masses up to 3 mm in diameter; and fish over 5 years old exhibiting 1 or more white, cerebriform masses greater than 1 cm in diameter. Histologic diagnoses of the tumors were predominantly spindle cell sarcomas or benign or malignant peripheral nerve sheath neoplasms, with fewer epitheliomas and carcinomas. Prevalence estimates did not vary significantly between sexes or season. The cause of this epizootic remains unclear. Tumor transmission trials, virus isolation procedures, and ultrastructural study of lesions failed to reveal evidence of a viral etiology. The Finger Lakes in which the disease occurred did not receive substantially more chemical pollution than unaffected lakes in the same chain during the epizootic, making an environmental carcinogen an unlikely primary cause of the epizootic. A hereditary component, however, may have contributed to this syndrome since only fish of the Seneca Lake strain were affected.
Asunto(s)
Enfermedades de los Peces/patología , Sistema de la Línea Lateral/patología , Neoplasias/veterinaria , Trucha , Animales , Técnicas de Cultivo de Célula/veterinaria , Epidemias/veterinaria , Femenino , Enfermedades de los Peces/epidemiología , Agua Dulce , Cabeza/patología , Inmunohistoquímica/veterinaria , Inflamación/veterinaria , Lagos , Sistema de la Línea Lateral/enzimología , Sistema de la Línea Lateral/ultraestructura , Masculino , Microscopía Electrónica/veterinaria , Neoplasias/epidemiología , Neoplasias/patología , New York/epidemiología , Prevalencia , ADN Polimerasa Dirigida por ARN/análisisRESUMEN
Loss of mechanosensory hair cells in the inner ear accounts for many hearing loss and balance disorders. Several beneficial pharmaceutical drugs cause hair cell death as a side effect. These include aminoglycoside antibiotics, such as neomycin, kanamycin and gentamicin, and several cancer chemotherapy drugs, such as cisplatin. Discovering new compounds that protect mammalian hair cells from toxic insults is experimentally difficult because of the inaccessibility of the inner ear. We used the zebrafish lateral line sensory system as an in vivo screening platform to survey a library of FDA-approved pharmaceuticals for compounds that protect hair cells from neomycin, gentamicin, kanamycin and cisplatin. Ten compounds were identified that provide protection from at least two of the four toxins. The resulting compounds fall into several drug classes, including serotonin and dopamine-modulating drugs, adrenergic receptor ligands, and estrogen receptor modulators. The protective compounds show different effects against the different toxins, supporting the idea that each toxin causes hair cell death by distinct, but partially overlapping, mechanisms. Furthermore, some compounds from the same drug classes had different protective properties, suggesting that they might not prevent hair cell death by their known target mechanisms. Some protective compounds blocked gentamicin uptake into hair cells, suggesting that they may block mechanotransduction or other routes of entry. The protective compounds identified in our screen will provide a starting point for studies in mammals as well as further research discovering the cellular signaling pathways that trigger hair cell death.
Asunto(s)
Aminoglicósidos/antagonistas & inhibidores , Cisplatino/antagonistas & inhibidores , Células Ciliadas Auditivas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Aminoglicósidos/toxicidad , Animales , Antibacterianos/antagonistas & inhibidores , Antibacterianos/toxicidad , Antineoplásicos/antagonistas & inhibidores , Antineoplásicos/toxicidad , Muerte Celular/efectos de los fármacos , Línea Celular Tumoral , Cisplatino/toxicidad , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Interacciones Farmacológicas , Gentamicinas/antagonistas & inhibidores , Gentamicinas/toxicidad , Células Ciliadas Auditivas/patología , Humanos , Kanamicina/antagonistas & inhibidores , Kanamicina/toxicidad , Sistema de la Línea Lateral/efectos de los fármacos , Sistema de la Línea Lateral/patología , Mecanotransducción Celular/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Neomicina/antagonistas & inhibidores , Neomicina/toxicidad , Moduladores Selectivos de los Receptores de Estrógeno/farmacología , Pez CebraRESUMEN
The zebrafish lateral line is an efficient model system for the evaluation of chemicals that protect and damage hair cells. Located on the surface of the body, lateral line hair cells are accessible for manipulation and visualization. The zebrafish lateral line system allows rapid screens of large chemical libraries, as well as subsequent thorough evaluation of interesting compounds. In this review, we focus on the results of our previous screens and the evolving methodology of our screens for chemicals that protect hair cells, and chemicals that damage hair cells using the zebrafish lateral line.